| Literature DB >> 35150310 |
Silke Brodkorb1, Irina Sidorenko2, Varvara Turova3, Esther Rieger-Fackeldey4, Ursula Felderhoff-Müser5, Andrey Kovtanyuk3, Renée Lampe6.
Abstract
One of the most feared neurological complications of premature birth is intraventricular hemorrhage, frequently triggered by fluctuations in cerebral blood flow (CBF). Although several techniques for CBF measurement have been developed, they are not part of clinical routine in neonatal intensive care. A promising tool for monitoring of CBF is its numerical assessment using standard clinical parameters such as mean arterial pressure, carbon dioxide partial pressure (pCO2) and oxygen partial pressure (pO2). A standard blood gas analysis is performed on arterial blood. In neonates, capillary blood is widely used for analysis of blood gas parameters. The purpose of this study was the assessment of differences between arterial and capillary analysis of blood gases and adjustment of the mathematical model for CBF calculation to capillary values. The statistical analysis of pCO2 and pO2 values collected from 254 preterm infants with a gestational age of 23-30 weeks revealed no significant differences between arterial and capillary pCO2 and significantly lower values for capillary pO2. The estimated mean differences between arterial and capillary pO2 of 15.15 mmHg (2.02 kPa) resulted in a significantly higher CBF calculated for capillary pO2 compared to CBF calculated for arterial pO2. Two methods for correction of capillary pO2 were proposed and compared, one based on the mean difference and another one based on a regression model.Entities:
Keywords: Arterial and capillary blood gas analysis; Bland–Altman’s plot; Cerebral blood flow; Intraventricular hemorrhage; Preterm birth; Regression model
Mesh:
Substances:
Year: 2022 PMID: 35150310 PMCID: PMC9056440 DOI: 10.1007/s00431-022-04392-0
Source DB: PubMed Journal: Eur J Pediatr ISSN: 0340-6199 Impact factor: 3.860
Basic clinical parameters of the study population
| Parameter | Whole cohort | Control group | Affected group | ||
|---|---|---|---|---|---|
| Gestational age (WG) | 26.5 ± 2.1 | 26.7 ± 2.2 | 26.3 ± 2.0 | 0.1 | |
| Birth weight (g) | 864.1 ± 279.1 | 850.7 ± 252.8 | 875.7 ± 300.5 | 0.7 | |
| Male | 122 (48%) | 48 (40.7%) | 74 (54.4%) | 0.03 | |
| Multiple birth | 95 (37.4%) | 43 (36.4%) | 52 (38.2%) | 0.8 | |
| APGAR | 1 min | 5.7 ± 2.2 | 6.2 ± 2.0 | 5.2 ± 2.2 | < 0.01 |
| 5 min | 7.1 ± 1.7 | 7.5 ± 1.4 | 6.8 ± 1.8 | < 0.01 | |
| 10 min | 8.0 ± 1.2 | 8.4 ± 1.0 | 7.7 ± 1.4 | < 0.01 | |
| Intubation during first 10 days [days] | 4.7 ± 4.0 | 3.8 ± 4.1 | 5.5 ± 3.8 | < 0.01 | |
| Neonatal bowel perforation (spontaneous/focal intestinal perforation SIP/FIP) | 23 (9.1%) | 3 (2.5%) | 20 (14.7%) | < 0.01 | |
| Metabolic acidosis | 23 (9.1%) | 0 | 23 (16.9%) | < 0.01 | |
| EPH gestosis/preeclampsia | 25 (9.8%) | 18 (15.3%) | 7 (5.1%) | 0.01 | |
| Cholestasis | 12 (4.7%) | 1 (0.8%) | 11 (8.1%) | 0.01 | |
| Pulmonary hemorrhage | 21 (8.3%) | 5 (4.2%) | 16 (11.8%) | 0.04 | |
| Erythrocyte blood transfusion | 164 (64.6%) | 71 (60.1%) | 93 (68.4%) | 0.2 | |
| Sepsis | 120 (47.2%) | 50 (42.4%) | 70 (51.5%) | 0.2 | |
| Preterm premature rupture of membranes (PPROM) | 73 (28.7%) | 39 (33.1%) | 34 (25.0%) | 0.2 | |
| Chorioamnionitis/amniotic infection syndrome | 117 (46.1%) | 50 (42.4%) | 67 (49.3%) | 0.3 | |
| Pulmonary stenosis | 4 (1.6%) | 3 (2.5%) | 1 (0.7%) | 0.3 | |
| Intrauterine growth retardation (IUGR) | 14 (5.5%) | 8 (6.8%) | 6 (4.4%) | 0.4 | |
| Respiratory distress syndrome (RDS) | 84 (33.1%) | 42 (35.6%) | 42 (30.9%) | 0.5 | |
| In vitro fertilization (IVF) | 32 (12.6%) | 17 (14.4%) | 15 (11.0%) | 0.5 | |
| Disseminated intravascular coagulation (DIC) | 2 (0.8%) | 0 | 2 (1.5%) | 0.5 | |
| Respiratory acidosis | 1 (0.4%) | 1 (0.8%) | 0 | 0.5 | |
| Necrotizing enterocolitis (NEC) | 20 (7.9%) | 8 (6.8%) | 12 (8.8%) | 0.6 | |
| Feto-fetal transfusion syndrome (FFTS) | 8 (3.1%) | 4 (3.4%) | 4 (2.9%) | 1 | |
*p-values are calculated for difference between control and affected groups
Number of arterial and capillary blood measurements
| Weeks of gestation | No IVH | With IVH | |||||
|---|---|---|---|---|---|---|---|
| Arterial | Capillary | Paired | Arterial | Capillary | Paired | ||
| 23 | 164 | 114 | 26 | 293 | 90 | 26 | |
| 24 | 327 | 194 | 26 | 315 | 154 | 51 | |
| 25 | 139 | 227 | 26 | 272 | 192 | 47 | |
| 26 | 104 | 250 | 14 | 291 | 135 | 19 | |
| 27 | 89 | 150 | 11 | 119 | 112 | 12 | |
| 28 | 11 | 223 | 0 | 162 | 123 | 18 | |
| 29 | 8 | 104 | 0 | 105 | 87 | 14 | |
| 30 | 0 | 102 | 0 | 6 | 72 | 3 | |
| All | 842 | 1364 | 103 | 1563 | 965 | 190 | |
Fig. 1Mean values of the arterial and capillary blood measurements of pCO2 (a) and pO2 (b) versus gestational age
Mean values and standard deviations of arterial and capillary blood gases
| Parameter | Unpaired measurements | Paired measurements | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Arterial | Capillary | Mean (art-cap) | Arterial | Capillary | Mean (art-cap) | ||||
| pCO2 (mmHg) | 47.41 ± 10.93 | 46.84 ± 9.53 | 0.11 | 0.57 | 45.90 ± 10.16 | 46.42 ± 9.13 | 0.38 | −0.52 | |
| pO2 (mmHg) | 50.67 ± 12.75 | 38.04 ± 7.78 | < 0.001 | 12.63 | 52.11 ± 11.84 | 36.96 ± 5.85 | < 0.001 | 15.15 | |
*p-values are calculated using two-sided Wilcoxon’s rank-sum test
**p-values are calculated using paired-sample t-test
Fig. 2Mean values of CBF calculated from arterial (solid lines) and capillary (dashed lines) blood measurements versus gestational age: a capillary pO2 values without correction; b capillary pO2 measurements corrected with mean difference (dashed lines without symbols: pO2cap + 15.15 mmHg) or with linear regression (circles: 0.64·pO2cap + 28.32 mmHg)
Mean values and standard deviations of CBF calculated from arterial and capillary blood measurements without and with correction of capillary pO2. The p-values* are calculated versus CBF computed using pO2art. The pIVH-values* are calculated for the difference between control and affected groups. The pdif-values* are calculated for the difference in correction methods
| pO2 (mmHg) | CBF (ml/100 g/min) | CBF (ml/100 g/min) | |
|---|---|---|---|
| pO2art | 8.99 ± 4.61 | 11.42 ± 9.33 | 0.39 |
| pO2cap (no correction) | 17.76 ± 8.76 | 18.76 ± 11.18 | 0.51 |
| pO2upM (correction I) | 12.82 ± 5.57 | 13.13 ± 7.19 | 0.79 |
| pO2pM (correction II) | 12.43 ± 5.29 | 12.65 ± 6.79 | 0.79 |
| pO2pR (correction III) | 12.24 ± 5.06 | 12.32 ± 6.45 pa = 0.96 | 0.79 |
*p, pIVH, and pdif values are calculated using two-sided Wilcoxon’s rank-sum test
Fig. 3a Scatter plot for capillary and arterial measurements of pO2. Dashed and dotted lines indicate mean and mean ± 2 standard deviation of variables on the corresponding axis. b Bland–Altman plot for the difference between capillary and arterial measurements of pO2. Dashed and dotted lines indicate mean difference and 95% limits of agreement for the difference pO2art − pO2cap
The difference between arterial and capillary measurements of pO2 using linear regression models
| Difference (mmHg) | Mean (mmHg) | Intercept (mmHg) | Slope | |
|---|---|---|---|---|
| pO2art − pO2cap | 15.15 | 28.32 | −0.36 | 0.002 |
| pO2art − pO2pM | 5.2·10¯15 | 13.17 | −0.36 | 0.002 |
| pO2art − pO2pR | −4·10¯16 | −1·10¯14 | 2·10¯16 | 1 |
*p-values are calculated using F-statistic versus constant model